CASIA OpenIR

浏览/检索结果: 共17条,第1-10条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Reconstruction based on adaptive group least angle regression for fluorescence molecular tomography 期刊论文
BIOMEDICAL OPTICS EXPRESS, 2023, 卷号: 14, 期号: 5, 页码: 2225-2239
作者:  An, Yu;  Wang, Hanfan;  Li, Jiaqian;  Li, Guanghui;  Ma, Xiaopeng;  Du, Yang;  Tian, Jie
收藏  |  浏览/下载:43/0  |  提交时间:2023/11/17
A Fast and Automated FMT/XCT Reconstruction Strategy Based on Standardized Imaging Space 期刊论文
IEEE TRANSACTIONS ON MEDICAL IMAGING, 2022, 卷号: 41, 期号: 3, 页码: 657-666
作者:  An, Yu;  Bian, Chang;  Yan, Daxiang;  Wang, Hanfan;  Wang, Yu;  Du, Yang;  Tian, Jie
Adobe PDF(8285Kb)  |  收藏  |  浏览/下载:293/58  |  提交时间:2022/06/06
Imaging  Image reconstruction  Mice  In vivo  Image segmentation  Finite element analysis  Surface reconstruction  Fluorescence molecular tomography  imaging reconstruction  standardized imaging space  
Peptidic microarchitecture-trapped tumor vaccine combined with immune checkpoint inhibitor or PI3K gamma inhibitor can enhance immunogenicity and eradicate tumors 期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 卷号: 10, 期号: 2, 页码: 13
作者:  Du, Yang;  Liu, Ye;  Wang, Di;  Bai, Hua;  Wang, Zhijie;  He, Xiran;  Zhang, Pei;  Tian, Jie;  Wang, Jie
收藏  |  浏览/下载:205/0  |  提交时间:2022/06/06
immunotherapy  immunogenicity  vaccine  tumor microenvironment  lymphocytes  tumor infiltrating  macrophages  
Application of Noninvasive Imaging to Combined Immune Checkpoint Inhibitors for Breast Cancer: Facts and Future 期刊论文
MOLECULAR IMAGING AND BIOLOGY, 2022, 页码: 16
作者:  Cheng, Zhongquan;  Du, Yang;  Yu, Leyi;  Yuan, Zhu;  Tian, Jie
收藏  |  浏览/下载:208/0  |  提交时间:2022/03/17
Noninvasive imaging  Immune checkpoint inhibitor  Combined immunotherapy  Breast cancer  
ImmunoAIzer: A Deep Learning-Based Computational Framework to Characterize Cell Distribution and Gene Mutation in Tumor Microenvironment 期刊论文
CANCERS, 2021, 卷号: 13, 期号: 7, 页码: 21
作者:  Bian, Chang;  Wang, Yu;  Lu, Zhihao;  An, Yu;  Wang, Hanfan;  Kong, Lingxin;  Du, Yang;  Tian, Jie
Adobe PDF(14076Kb)  |  收藏  |  浏览/下载:257/23  |  提交时间:2021/05/17
deep learning  cell distribution  biomarker  tumor gene mutation  tumor microenvironment (TME)  semi-supervised learning  hematoxylin and eosin (H&  E)  
Integrating No.3 lymph nodes and primary tumor radiomics to predict lymph node metastasis in T1-2 gastric cancer 期刊论文
BMC Medical Imaging, 2021, 卷号: 21, 期号: 1, 页码: 10
作者:  Wang,Xiaoxiao;  Li,Cong;  Fang,Mengjie;  Zhang,Liwen;  Zhong,Lianzhen;  Dong,Di;  Tian,Jie;  Shan,Xiuhong
Adobe PDF(2269Kb)  |  收藏  |  浏览/下载:371/57  |  提交时间:2021/04/06
Stomach cancer  Lymph nodes  Nomogram  
Combination Immunotherapy with Cytotoxic T-Lymphocyte-Associated Antigen-4 and Programmed Death Protein-1 Inhibitors Prevents Postoperative Breast Tumor Recurrence and Metastasis 期刊论文
MOLECULAR CANCER THERAPEUTICS, 2020, 卷号: 19, 期号: 3, 页码: 802-811
作者:  Sun, Ting;  Zhang, Wenjia;  Li, Yuan;  Jin, Zhengyu;  Du, Yang;  Tian, Jie;  Xue, Huadan
收藏  |  浏览/下载:246/0  |  提交时间:2020/04/07
Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker 期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 卷号: 8, 期号: 2, 页码: 10
作者:  He, Bingxi;  Dong, Di;  She, Yunlang;  Zhou, Caicun;  Fang, Mengjie;  Zhu, Yongbei;  Zhang, Henghui;  Huang, Zhipei;  Jiang, Tao;  Tian, Jie;  Chen, Chang
Adobe PDF(5232Kb)  |  收藏  |  浏览/下载:320/54  |  提交时间:2020/08/24
immunotherapy  lung neoplasms  tumor microenvironment  biomarkers  tumor  biostatistics  
Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma 期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 卷号: 8, 期号: 2, 页码: 15
作者:  He, Xiran;  Du, Yang;  Wang, Zhijie;  Wang, Xin;  Duan, Jianchun;  Wan, Rui;  Xu, Jiachen;  Zhang, Pei;  Wang, Di;  Tian, Yanhua;  Han, Jiefei;  Fei, Kailun;  Bai, Hua;  Tian, Jie;  Wang, Jie
收藏  |  浏览/下载:230/0  |  提交时间:2021/01/06
drug therapy  combination  immunotherapy  lung neoplasms  lymphocytes  tumor-infiltrating  translational medical research  
Noninvasive Imaging for Assessment of the Efficacy of Therapeutic Agents for Hepatocellular Carcinoma 期刊论文
Molecular Imaging and Biology, 2019, 期号: 10.1007/s11307-019-01431-5, 页码: 1-14
作者:  Liang, Qian;  Kong, Lingxin;  Zhu, Xu;  Du, Yang;  Tian, Jie
浏览  |  Adobe PDF(3951Kb)  |  收藏  |  浏览/下载:311/109  |  提交时间:2020/06/03
Hepatocellular carcinoma  Molecular imaging  Preclinical drug evaluation  Clinical trial  Therapeutics